Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells

被引:40
作者
Fonseca, C
Moreira, JN
Ciudad, CJ
de Lima, MCP
Simoes, S [1 ]
机构
[1] Univ Coimbra, Fac Pharm, Pharmaceut Technol Lab, P-3030 Coimbra, Portugal
[2] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3030 Coimbra, Portugal
[3] Univ Coimbra, Fac Sci & Technol, Dept Biochem, P-3030 Coimbra, Portugal
[4] Univ Barcelona, Sch Pharm, Dept Biochem & Mol Biol, Barcelona, Spain
关键词
nanotechnology; pH-sensitive liposomes; targeting; transferrin; human T-leukaemia cells; cancer therapy;
D O I
10.1016/j.ejpb.2004.08.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main aim of this work was to develop novel targeted sterically stabilised pH-sensitive liposomes tailored to promote efficient intracellular delivery of therapeutic molecules into human T-leukaemia cells. Our results indicate that the targeting moiety (thiolated transferrin) was successfully coupled to the distal reactive maleimide terminus of poly(ethylene glycol)-phospholipid conjugates incorporated in the liposomal bilayer. Results from atomic force microscopy studies, performed to characterise vesicle surface topology, indicated that, to a certain extent, thiolated transferrin has the ability to associate in a non-specific manner with the lipid membrane of pegylated liposomes. This is an issue not commonly reported in the literature but which is crucial to demonstrate the targeting proof of principle. Nevertheless, fluorimetric studies together with confocal microscopy clearly demonstrate that liposomes bearing covalently coupled transferrin associate more extensively to human T-leukaemia cells in vitro than non-targeted liposomes. Cell mechanistic studies indicate that targeted liposomes bind specifically to transferrin receptors and are internalised via receptor-dependent endocytotic pathway. In addition, the biophysical features exhibited by the developed liposomes, namely their ability to promote pH-triggered cytoplasmic delivery of loaded material, make them promising delivery systems for in vivo targeting of therapeutic molecules to tumours. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 32 条
[1]   Ligand-targeted therapeutics in anticancer therapy [J].
Allen, TM .
NATURE REVIEWS CANCER, 2002, 2 (10) :750-763
[2]   A NEW STRATEGY FOR ATTACHMENT OF ANTIBODIES TO STERICALLY STABILIZED LIPOSOMES RESULTING IN EFFICIENT TARGETING TO CANCER-CELLS [J].
ALLEN, TM ;
BRANDEIS, E ;
HANSEN, CB ;
KAO, GY ;
ZALIPSKY, S .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1237 (02) :99-108
[3]  
[Anonymous], 1993, J LIPOSOME RES, DOI DOI 10.3109/08982109309148213]
[4]   Targetability of novel immunoliposomes prepared by a new antibody conjugation technique [J].
Bendas, G ;
Krause, A ;
Bakowsky, U ;
Vogel, J ;
Rothe, U .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 181 (01) :79-93
[5]  
BERGKVIST M, 1998, 6 FOR C MOL NAN SANT
[6]   Atomic force microscopy of liposomes bearing fibrinogen [J].
Casals, E ;
Verdaguer, A ;
Tonda, R ;
Galán, A ;
Escolar, G ;
Estelrich, J .
BIOCONJUGATE CHEMISTRY, 2003, 14 (03) :593-600
[7]  
Derycke ASL, 2002, INT J ONCOL, V20, P181
[8]   Current status of pH-sensitive liposomes in drug delivery [J].
Drummond, DC ;
Zignani, M ;
Leroux, JC .
PROGRESS IN LIPID RESEARCH, 2000, 39 (05) :409-460
[9]   FORMATION AND PROPERTIES OF 1000-A-DIAMETER, SINGLE-BILAYER PHOSPHOLIPID VESICLES [J].
ENOCH, HG ;
STRITTMATTER, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (01) :145-149
[10]  
Fiske CH, 1925, J BIOL CHEM, V66, P375